Human ORCTL-2 Antibody (GWB-ASD822) (Aviva Cat. No. OAAF02607)

This exact product is available to purchase through Aviva Systems Biology.
Please see item number OAAF02607 to view product details and for ordering information.


Aviva Cat. No.: OAAF02607


Description: ORCTL-2 Antibody detects endogenous levels of total ORCTL-2 protein.

Additional Information

Name Human ORCTL-2 Antibody (GWB-ASD822)
Related Product Names Solute carrier family 22 member 18, Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene A protein, Efflux transporter-like protein, Imprinted multi-membrane-spanning polyspecific transporter-related protein 1, Organic cation transporter-like p
Gene Symbol SLC22A18
Gene Family SLC
Gene Fullname Solute carrier family 22 member 18
Gene id 5002
Swissprot ID Q96BI1
Protein Name Solute carrier family 22 member 18
Protein Accession Num NP_002546.3
Application Info WB: 1:500~1:3000; ELISA: 1:5000
Host Rabbit
Immunogen The antiserum was produced against synthesized peptide derived between 359-408 amino acids from the C-Terminal region of human ORCTL-2.
Replacement This antibody may replace item sc-109741 from Santa Cruz Biotechnology.
Product Format Liquid
Formulation Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Specificity ORCTL-2 antibody detects endogenous levels of total ORCTL-2 protein.
Concentration 1 mg/ml
Application WB ELISA
GI Number 5002
Stability 1 year
Reconstitution and Storage Store at -20C/1 year
Reactivity Human
Datasheets/Manuals Printable datasheet for GWB-ASD822
Storage Store at -20C
Dilution The optimal working dilution should be determined by the end user.
Species Reactivity Human
Lead Time Domestic: within 2-3 weeks delivery | International: 2-3 weeks
Intended Use Research Use Only
Key Reference Lee M.P., Cancer Res. 58:4155-4159(1998).
Morisaki H., DNA Res. 5:235-240(1998).
Cooper P.R., Genomics 49:38-51(1998).